XML 35 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivative Instruments and Fair Value Measurements
12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Fair Value Measurements Derivative Instruments and Fair Value Measurements
Derivative Instruments

At December 31, 2023, we had in place no derivative instruments. At December 31, 2022, we had in place three derivative instruments, entered into in 2022 for a total of 300,000 barrels of crude oil to be purchased and sold in January 2023, and one derivative instrument, also entered into in 2022, for the purchase of 126,000 gallons of diesel fuel per month during January 2023 through December 2023.
The estimated fair value of forward month derivative instruments reflected in the accompanying consolidated balance sheets were as follows at the dates indicated (in thousands):
Balance Sheet Location and Amount
CurrentOtherCurrentOther
December 31, 2023
Assets
AssetsLiabilitiesLiabilities
Asset derivatives:
Fair value forward hydrocarbon derivative
instruments at gross valuation$— $— $— $— 
Liability derivatives:
Fair value forward hydrocarbon derivative
instruments at gross valuation— — — — 
Less counterparty offsets— — — — 
As reported fair value contracts$— $— $— $— 
December 31, 2022
Asset derivatives:
Fair value forward hydrocarbon derivative
instruments at gross valuation$ $— $— $— 
Liability derivatives:
Fair value forward hydrocarbon derivative
instruments at gross valuation— — 330 — 
Less counterparty offsets— — — — 
As reported fair value contracts$— $— $330 $— 
We only enter into derivative instruments with creditworthy counterparties and evaluate our exposure to significant counterparties on an ongoing basis. At December 31, 2023 and 2022, we were not holding nor have we posted any collateral to support our forward month fair value derivative activity. We are not subject to any credit-risk related trigger events. We have no other financial investment arrangements that would serve to offset our derivative contracts.

Forward month derivative instruments reflected in the accompanying consolidated statements of operations were as follows for the periods indicated (in thousands):

Gains (Losses)
Year Ended December 31,
202320222021
Revenues – marketing
$— $(23)$14 
Costs and expenses – marketing(330)330 — 
Fair Value Measurements

The following table reflects, by level with the Level 1, 2 and 3 fair value hierarchy, the carrying values of our financial assets and liabilities at the dates indicated (in thousands):

Fair Value Measurements Using
Quoted Prices
in ActiveSignificant
Markets forOtherSignificant
Identical AssetsObservableUnobservable
and LiabilitiesInputsInputsCounterparty
(Level 1)(Level 2)(Level 3)OffsetsTotal
December 31, 2023
Derivatives:
Current assets$— $— $— $— $— 
Current liabilities— — — — — 
Net value$— $— $— $— $— 
December 31, 2022
Derivatives:
Current assets$— $— $— $— $— 
Current liabilities— (330)— — (330)
Net value$— $(330)$— $— $(330)

These assets and liabilities are measured on a recurring basis and are classified based on the lowest level of input used to estimate their fair value. Our assessment of the relative significance of these inputs requires judgments.

When determining fair value measurements, we make credit valuation adjustments to reflect both our own nonperformance risk and our counterparty’s nonperformance risk. When adjusting the fair value of derivative contracts for the effect of nonperformance risk, we consider the impact of netting and any applicable credit enhancements. Credit valuation adjustments utilize Level 3 inputs, such as credit scores to evaluate the likelihood of default by us or our counterparties. At December 31, 2023 and 2022, credit valuation adjustments were not significant to the overall valuation of our fair value contracts. As a result, applicable fair value assets and liabilities are included in their entirety in the fair value hierarchy.